摘要
新辅助治疗联合手术是一种非常具有医学前景的食管癌临床治疗策略,综合其有效性和安全性,新辅助放疗可作为重度食管癌、不可切除食管癌的治疗手段,新辅助化疗在腺癌中治疗价值更高,新辅助放化疗可作为鳞状细胞癌患者的推荐治疗方案。
Neoadjuvant therapy combined with surgery is a very promising clinical treatment strategy for esophageal cancer.Combined with its effectiveness and safety,neoadjuvant radiotherapy can be used as a treatment method for severe esophageal cancer and unresectable esophageal cancer.Neoadjuvant chemotherapy has a higher value in the treatment of adenocarcinoma.Neoadjuvant cheoradiotherapy can be used as the recommended treatment scheme for patients with squamous cancer.
作者
卜茜
黄俊星
Bu Qian;Huang Junxing(School of Medicine,Jiangsu University,Zhenjiang 212000,China;Department of Oncology,People's Hospital of Taizhou of Jiangsu Province,Taizhou 225300,China)
出处
《国际肿瘤学杂志》
CAS
2020年第4期244-248,共5页
Journal of International Oncology
关键词
食管肿瘤
肿瘤
鳞状细胞
腺癌
肿瘤辅助疗法
Esophageal neoplasms
Neoplasms
squamous cell
Adenocarcinoma
Neoadjuvant therapy
